FASLG and central nervous system cancer: The use of monoclonal antibodies to crosslink sFasL is associated with liver toxicity (54), whereas a synthetic human hexameric FasL (APO010, Topotarget) promotes human glioma cell death and prolongs survival in tumor-bearing mice with no need for crosslinkers (55).